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BIOMARKERS OF CHRONIC STRESS 
Laalithya Konduru, M.S. 
University of Pittsburgh, 2011 
 Stress is defined as the internal process that occurs when a person is faced with 
a demand that is perceived to exceed the resources available to effectively deal with it. 
It can be either acute or chronic. The current approaches to measure stress include self 
reports, measures of affect, measures of stressor exposure and use of biomarkers. This 
paper seeks to act as a review of the various neuroendocrine biomarkers for chronic 
stress. A brief overview of metabolic and immunological biomarkers is also included. 
Serum cholesterol, serum albumin, waist-hip ratio and glycosylated hemoglobin are 
some of the common metabolic biomarkers. IL-6, TNF-α, CRP and IGF-1 are some of 
the common immunological biomarkers. Neuroendocrine factors are effective as 
biomarkers because they are the first to respond to a given stressor and coordinate the 
response of many other biological systems. Cortisol, DHEA, adrenaline, noradrenaline, 
dopamine and aldosterone are some of the commonly used neuroendocrine 
biomarkers. Use of any single biomarker for stress is associated with problems of 
multiple determination. Allostatic load model utilizes a suite of indicators to measure the 
effects of stress across many physiological systems. Use of novel technologies like 
metabolomics, determining changes in ultrastructure of mitochondria and quantifying 
the induction of DRR1 in the brain are some interesting research areas that could throw 
up novel biomarkers. Chronic stress is associated with many diseases. It can possibly 
potentiate the health effects of various exposures and thus, it is an important public 
health concern. In order to conduct research on any given condition, it is important to 
characterize that condition. Biomarkers can help characterize stress objectively. Stress, 
unlike any other pathological condition, triggers a non-specific response and influences 
multiple physiological systems. Ideally, a study would use a set of biomarkers to 
measure stress response, while using questionnaires to measure stressor exposure and 
stress appraisal. The challenge lies in coming up with a set of biomarkers that can 
capture the chronic stress related information and weed out other confounding factors.  
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1.0 INTRODUCTION 
   
Stress is an integral part of our lives. Every organism that lives, experiences 
some form of stress or the other during its lifetime. In recent times, the term “stress” has 
been frequently used in popular parlance. While stress can be psychosocial, physical or 
chemical, the focus of this paper is on psychosocial stress. According to Lazarus, stress 
is defined as an internal process that occurs when a person is faced with a demand that 
is perceived to exceed the resources available to effectively respond to it, and where 
failure to effectively deal with the demand has important undesirable consequences [1]. 
When under stress, the body responds in a way similar to how it responds to danger. 
Fatigue, being generally ill and feeling jittery are all sensations of stress [2].  
Stress causes certain changes in the structure and chemical composition of the 
body, which can be accurately appraised. Some of these changes are merely signs of 
damage, while others are manifestations of the body`s defensive adaptive reactions [1]. 
These changes caused by stress, collectively called the General Adaptation Syndrome, 
develop in three stages – the alarm reaction, stage of resistance, and stage of 
exhaustion [3].  
The alarm reaction is the initial stage of the general adaptation syndrome, in 
which the body responds by exhibiting shock. Selye has called it “the bodily expression 
of the generalized call to arms of the defensive forces of the organism" [1]. It is triggered 
by the perception of a stressor, which leads to the arousal of physiological systems [4]. 
This physiological arousal is the basis for the fight-or-flight response [5]. The alarm 
reaction is characterized by adaptive physiological changes like increased heart rate, 
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increased hormonal activity, etc. The stage of resistance is the second stage. The body 
tries to defend itself by fending off the stressor and attaining homeostasis. It is 
characterized by increased heart rate and muscle tone, production of stress hormones, 
etc. Levels of endocrine and sympathetic activity are lower than during the alarm 
reaction, but higher than normal [4]. Energy sources are spent, the organism becomes 
vulnerable to diseases and usually, reactions are overdone or excessive. If the stress 
persists, and additional stress in any form is encountered, the third stage – the stage of 
exhaustion occurs, which results in the breakdown of the body`s defense mechanism 
[5]. Muscles become fatigued and the body is depleted of resources required to combat 
stress. Continued exposure to stress during the stage of exhaustion leads to the 
development of diseases [3]. Over-stress causes a wide range of harmful effects 
including development of ulcers, heart disorders, predisposition to musculoskeletal 
injury, etc [5]. 
According to Lazarus`s cognitive theory of stress, there are three components of 
stress - Stressor, Stress Appraisal, Stress Response. The stressor is any event, 
condition or external stimulus that poses a physical or psychological challenge. Stress 
appraisal is how a person perceives the stressor. Stress responses are the 
physiological and psychological consequences of stress appraisal [6].  
A stressor can be appraised as harm/loss (the harm/loss already suffered by the 
individual) or threat (expected harm/loss) or challenge (stressors out of which a gain is 
possible for the individual). The feeling of vulnerability to the stressor (perceiving the 
stressor as stressful) depends on cognitive appraisal. A person feels vulnerable when 
he/she feels that they don’t have enough resources for coping with a given stressor. 
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The perceived significance of the potential harm/loss also shapes vulnerability [1]. 
Hence, what is stressful for one person may not be stressful for another.  
The biopsychosocial model is one of the most comprehensive models of stress.  
this model incorporates the previous models of stress into its framework. According to 
the this model proposed by Bernard and Krupat, stress involves three components, an 
external component, an internal component and an interaction between the external and 
internal components. The external component of the Biopsychosocial Model of stress 
involves environmental events that precede the recognition of stress and can elicit a 
stress response. The internal component of stress involves a set of neurological and 
physiological reactions to stress. Selye, with his focus on the general adaptation 
syndrome dealt with the internal component. The third component of the 
biopsychosocial model of stress is the interaction between the external and internal 
components, involving the individual's cognitive processes. Lazarus`s cognitive theory 
of stress addresses this interaction [7].  
Dienstbier offers a reformulation of the cognitive theory, which focuses on the 
emotional consequences of appraising an event as a stressor or as a challenge. He 
asserts that when an event is appraised as a challenge, it lead to different physiological 
consequences than when it is appraised as a harm/loss or threat. Dienstbier uses the 
term stress to refer to transactions that lead only to negative emotions and he uses the 
term challenge to describe a transaction that could lead both to positive and negative 
emotions. A series of studies by Marianne Frankenhaeuser and colleagues provide 
some support for Dienstbier's assertion that a stressor evaluated as a challenge should 
be viewed more positively than a harm/loss or threat event [8]. According to 
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Frankenhaeuser, physiological reactions to stressors depend on two factors: effort and 
distress. She found that there are three categories of physiological responses to stress. 
Effort with distress leads to increases of both catecholamine and cortisol secretion and 
result from daily hassles. These stressors are experienced as negative emotions. This 
category corresponds to Dienstbier's characterization of the negative emotions present 
in an event appraised as a harm/loss or as a threat. Effort without distress leads to an 
increase of catecholamine and suppression of cortisol secretion. These stressors are 
experienced as positive emotions. This category corresponds to Dienstbier's 
characterization of the positive emotions present in events appraised as challenging. 
Distress without effort leads to increased cortisol secretion but not necessarily to 
catecholamine secretion. This is the pattern often found in depressed individuals [9]. 
Stress can either be acute (short term, generally lasting days to weeks) or 
chronic (longer term, generally lasting weeks to months). Acute stress is experienced in 
response to an immediate perceived threat. The autonomic nervous system is activated 
and there is an increase in cortisol and adrenalin levels, higher heart rate, quickened 
breathing, etc. The fight-or-flight response kicks in [10]. The term fight-or-flight was 
coined by Walter Cannon in the 1920s when he first described the acute stress 
response as a theory where an animal reacts to danger “with a general discharge of the 
sympathetic nervous system” [5]. Once the danger is averted, the body returns to 
homeostasis by activating the relaxation response, which is the opposite of the fight-or-
flight response, characterized by reduction of heart rate, decreased production of stress 
hormones, slower breathing, vasodilation, etc [11]. Chronic stress is a state of on-going 
physiological arousal. This occurs when the body experiences many stressors or a 
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single stressor continuously, that it does not have the ability or opportunity to activate 
the relaxation response [12]. It can develop in response to everyday stressors which are 
ignored or poorly managed, or in response to traumatic events [13]. It has many 
negative consequences including suppression of the immune system, increased risk of 
heart attacks and strokes, speeding up of the ageing process, infertility, etc [14]. 
Additionally, chronic stress can take a severe emotional toll. 
The current approaches to measure stress include Self report of stress (for eg., 
Perceived stress scale – questionnaire with questions designed to provide information 
about how unpredictable, uncontrollable and overloaded the respondents felt their lives 
to be. Based on the answers, a score is assigned. A high score on this scale has been 
correlated with failure to quit smoking, greater susceptibility to colds, etc. [15]) and 
Measures of affect (for eg., POMS questionnaire – assesses transient, fluctuating 
affective mood states. Consists of 6 identifiable affective states which are rated by the 
subjects on a 5 point scale [16]) which are measures of stress appraisal, Measures of 
stressor exposure (for eg., Major life events stress scale – a list of major events is given 
and subjects are asked to indicate which events they have experienced. Each event is 
given a weighted score and an overall score is given to each subject by summing the 
weighted scores of all events indicated. A high score correlates to high susceptibility to 
stress related illnesses [17]) which measures the stressor, using Biomarkers (for eg., 
Cortisol, CRP, IL-6), or using a composite set of parameters (Allostatic load model) 
which measure either the stressor or the stress response. Self reporting of stress, 
stressor exposure and measures of affect suffer from recall bias. Biomarkers are 
objective measurements, but they cannot be used in isolation to measure stress 
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because, unlike other pathological conditions which induce specific responses from the 
systems they affect, stress induces a generalized response from all systems of the body 
and each response can also be triggered by other conditions, i.e., the responses are 
multiply determined. Hence, when using a biomarker, it is necessary to interpret the 
results in the context of other existing pathological conditions. 
A biomarker is defined as a substance that can be used as an indicator of a 
biological state. It is a characteristic which can be objectively measured and evaluated 
as an indicator of that state [18]. Biomarkers are essential in order to effectively quantify 
stress. They can be used to objectively measure the physiological response to 
psychosocial stressors. They however, do not provide a direct measurement of the 
stress appraisal component, which plays a major role in determining if the given 
stressor is being perceived as harmful, beneficial or irrelevant. Stress appraisal need 
not always be a conscious process [1]. When a stressor is subconsciously perceived as 
stressful, in view of the stressor exposure, biomarkers can be used to measure the 
physiological responses. They also have immense diagnostic and prognostic value. 
Biomarker discovery is the process by which biomarkers are discovered. Biomarker 
discovery is based on clear biological insight, from physiology or biochemistry. Detailed 
knowledge of the mechanism of disease is usually required. A clear mechanistic 
understanding of stress is still evasive. Biomarkers for mechanistic studies are those 
based on some previous knowledge of the relationship between the disease and 
exposure being studied. These mechanistic studies lead to a more comprehensive 
understanding of the underlying mechanism, leading to the discovery of biomarkers that 
are closer to the clinical manifestation of the disease state and thus, can be used for 
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diagnostic purposes. These clinical biomarkers are useful to epidemiological studies. 
However, it is very difficult to separate out which biomarkers represent the underlying 
biology and which biomarkers arise as a consequence of stress. Biomarkers currently 
available to quantify stress, are based on limited mechanistic knowledge. These can be 
used in studies addressing the mechanisms underlying stress and disease. They have 
also been used successfully in various epidemiological studies despite the lack of a 
comprehensive understanding of the biological basis behind the behavior of the 
biomarker being measured. Biomarkers for stress can be grouped into Neuro-endocrine 
markers, Immune function markers, Metabolic markers and Morphological markers. 
Many biomarkers have been identified for both acute and chronic stress that fall into 
each of the four categories. Due to the problem of multiple determinations, the current 
challenge is to identify novel biomarkers or a combination of biomarkers and other 
parameters that can effectively measure stress, independent of other existing conditions 
in an individual. Also, biomarker measures may undergo variation within a given day or 
across the individual`s lifespan. Hence, when interpreting functional significance and 
predicting outcomes, a single measurement at a single time point can be misleading. An 
ideal biomarker for stress should be able to capture what is happening to the body in a 
naturalistic social environment. Since stress elicits a multi systemic non-specific 
response, searching for a single biomarker that can assess and quantify it is not 
realistic. It would be more meaningful to seek out a panel of biomarkers that can 
capture changes in various stress response systems to give a holistic picture of the 
physiological state of the body due to a given exposure to stress. 
 8 
 
The allostatic load model, proposed by McEwen and coworkers, is one such 
effort where a set of indices are measured simultaneously. The indices measured 
encompass the various physiological systems known to be influenced by chronic stress. 
It is advantageous to use the allostatic load model in place to standalone biomarkers 
because, stress affects many physiological systems simultaneously and the allostatic 
load model can capture changes in various systems and give an overall score which 
can be related to susceptibility to chronic stress related illness. Also, the problem of 
multiple determination can be mitigated to an extent because, it is unlikely that any 
given pathological condition would affect all the indices being measured in the same 
manner as chronic stress. This model will be been discussed in more detail later.[19] 
It has been suggested that males and females respond to stress differently, with 
a group of researchers hypothesizing that males are more likely to respond with 
aggression (fight) and females are more likely to respond with fleeing (flight) or turning 
to others for help and trying to diffuse the situation (tend and befriend) [20]. Though this 
is an important hypothesis, considering the fact that various hormones which are used 
as biomarkers for stress, behave differently in the two sexes, this paper will not dwell on 
the sex differences in stress response or biomarker behavior. 
 
 1.1 FACTORS THAT MAKE A STRESSOR STRESSFUL 
  
 Evidence suggests that unpredictable and uncontrollable events are more 
stressful than predictable and controllable events. Experiments have shown that when 
people believe some action can be taken regarding a given challenge, they perceive it 
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as less stressful, even if they do not take action [21]. Hence, lack of control is an 
important variable influencing appraisal of a given stressor. A second variable is 
suddenness. It is usually easier to cope with an event that one can foresee. Thirdly, 
ambiguity influences stress appraisal. This is because; it is easier to determine a course 
of action for a well defined situation, whereas ambiguity entails lot of energy expenditure 
towards understanding the nature of the stressor and evaluating possible coping 
mechanisms [22]. 
 
 1.2 SCOPE OF THE PAPER 
 
This paper seeks to act as a review of various neuro-endocrine indices currently 
available for measuring chronic stress. These indices can be used as biomarkers to aid 
mechanistic studies and can lead to a more well rounded understanding of chronic 
stress and a consequent discovery of biomarkers for epidemiological and diagnostic 
use. A brief overview of some metabolic and immunological biomarkers is also included 
and promising new directions of research in chronic stress characterization has also 
been discussed. 
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2.0 THE STRESS RESPONSE 
 
 A number of physiological systems respond to stress. The neuroendocrine 
system is the first to respond to stress and causes certain changes in the immune 
system, cardiovascular system, metabolism, etc [1]. Under a normally functioning 
system, stimulation of hypothalamus results in the secretion of Corticotropin releasing 
hormone (CRH). CRH stimulates the pituitary gland to secrete Adrenocorticotropic 
hormone (ACTH) [23]. ACTH in turn stimulates the adrenal glands to produce various 
hormones. These include aldosterone which has a direct effect on the kidneys [24], 
cortisol which has an effect on the immune system and brain [25-26], 5-
dehydroepiandrosterone (DHEA) which has an effect on the body`s metabolism [27] 
and adrenaline which has an effect on the cardiovascular system and respiration [28-
29]. Stress also results in the activation of the sympathetic nervous system. 
Sympathetic nervous system activation causes the adrenal glands to secrete 
noradrenaline, which has an effect on the cardiovascular system and respiration [28-
29].  
Chronic stress leads to prolonged activation of this stress response. 
Pregnenolone steal (or cortisol escape) is the body`s hormonal response to chronic 
stress. Pregnenolone is the precursor to all steroid hormones. Under chronic stress, the 
body utilizes most of this precursor for the synthesis of the principal stress hormone, 
cortisol. this results in imbalances and deficiencies in all other steroid hormones [30]. 
The diagram illustrates the chronic stress response [30].  
 11 
 
 
Figure 1. PREGNENOLONE STEAL 
Behavioral and morphological changes are also part of the chronic stress 
response. Negative emotional states are strongly associated with stress. The behavioral 
changes associated with long term stress exposure are diverse, but may be classed into 
four major types. The two common kinds of behaviors are based on the biological 
response of fight or flight. Though fight-or-flight is primarily an acute stress response, 
under chronic stress, an individual may become withdrawn and depressive, or become 
aggressive and irritable. The other two types of behaviors are adaptation and 
habituation [31-32]. At the cellular level, there are changes in the structural integrity of 
mitochondria, fragmentation of the Golgi complex, aggregation of cytoskeleton 
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structures, collapse of vimentin containing intermediate filaments around the nucleus, 
etc. have been observed [33-34]. Cortisol is able to cross the blood brain barrier and 
bind to receptors in the hippocampus and so, long term production of stress hormones 
is able to induce memory impairments, shrinking and atrophy of the hippocampus [35]. 
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3.0 METHOD USED FOR IDENTIFYING BIOMARKERS DISCUSSED IN THIS PAPER 
 
The biomarkers discussed in this paper were identified based on literature 
search. The Pubmed database was searched with the search phrase, “biomarkers of 
chronic psychosocial stress”. The various biomarkers used in the research articles 
shown in the results of the search were tabulated. The search was repeated with the 
search phrases, “metabolic markers of chronic psychosocial stress”, “immunological 
markers of chronic psychocosial stress”, “neuroendocrine markers of chronic 
psychosocial stress” and “biomarkers of chronic stress”. Some of the metabolic, 
immunological and neuroendocrine markers most frequently used in the studies 
presented as search results have been discussed. 
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4.0 METABOLIC BIOMARKERS 
 
Changes in metabolism are easily quantifiable and can be used as biomarkers 
for chronic stress. Cholesterol levels, Albumin, Waist-Hip ratio and Glycosylated 
hemoglobin are some of the parameters which quantify change in metabolism, currently 
in use as markers of chronic stress. 
 
4.1 SERUM CHOLESTEROL 
 
Serum cholesterol is the total level of cholesterol in the blood stream. The normal 
range of serum cholesterol is 120-250 mg/dL. Serum cholesterol levels drop under 
chronic stress. Various studies have suggested that serum cholesterol levels are 
decreased under chronic stress. Researchers at Bethesda, MD reported that after 
severe stress occurring during military training, the serum cholesterol concentration in 
navy trainees enrolled in the study decreased by 17.2% [36]. In a study conducted on 
monkeys, it was reported that in the presence of persistently high amounts of 
adrenaline, serum cholesterol levels drop [37]. Low serum cholesterol levels have also 
been observed in persons who suffered from accidents, persons showing aggressive 
behavior and in depression patients [38-40]. This lowering in serum cholesterol can be 
attributed to elevated endocytosis of lipoproteins by the action of ACTH and the 
intracellular hydrolysis of cholesterol either by the activation of cholesterol esterases or 
by the suppression of cholesterol acetyltransferase [41]. However, some studies have 
provided conflicting evidence. In a chronic stress study conducted on young men by the 
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United States army research institute of environmental medicine, it was reported that 
serum cholesterol levels rose progressively throughout the study period. [42]. Another 
study conducted in elderly persons found no significant difference in the level of serum 
cholesterol in stressed individuals and controls [43]. Cholesterol captures 
pathophysiology of liver, metabolism, and risk of cardiovascular disease. It can be used 
for large epidemiological studies to establish associations between cardiovascular 
disease and chronic stress because it can be measured easily from blood. It is more 
suited to toxicology studies because, to understand the significance of chronic stress 
and the level of cholesterol observed, it is necessary to be able to document cholesterol 
level before the onset of chronic stress. This information is usually not easy to collect in 
an epidemiology study. Confounding variables include age, smoking, hypertension, diet, 
etc. 
 
4.2 SERUM ALBUMIN 
 
Serum albumin is the most abundant protein in mammals. Albumin helps to 
transport many hydrophobic substances through the blood stream. The normal range is 
3-6 g/dL. The synthesis of albumin occurs only in hepatic cells, and its half life is about 
21 days. The rate at which it is synthesized is about 15 g per day in healthy individuals, 
and the rate of degradation is about 4% per day. These rates can vary significantly with 
stress. Hypoalbuminemia is linked to acute or chronic inflammatory responses. The 
levels have been reported to return to normal upon resolution of inflammation. Chronic 
stress, via various inflammatory or neuroendocrine mediators, could reduce albumin 
 16 
 
levels by either increasing the rate of degradation, or by reducing the rate of synthesis. 
Hypoalbuminemia can facilitate edema, which can result in further reduction in serum 
albumin, as more albumin can now enter the extra vascular space. In mice, TNF-α has 
been reported to suppresses the transcription of the alb gene [44-45]. Studies 
conducted on adult males have suggested that serum albumin levels can drop due to 
chronic stress and increase following resolution [46-47]. Serum albumin captures the 
pathophysiology of liver and metabolism. It can also capture nutritional state, which can 
either be an outcome of stress or a confounding exposure. Albumin can be easily 
measured from blood and hence is useful in animal studies and epidemiology studies, 
especially those studying associations between stress and nutrition. Many health 
conditions result in reductions of serum albumin, hence the findings must be analysed in 
view of such confounding. In animal studies where proper controls are used and 
baseline albumin levels are known, confounding from existing pathologies can be 
minimised. 
 
4.3 WAIST-HIP RATIO 
 
Waist-hip ratio tends to be higher for chronically stressed individuals. Bjorntorp 
[48] and Rebuffe-Scrive [49] have hypothesized that greater vulnerability to stress 
(perceiving a stressor as stressful) increases exposure to stress-induced cortisol, which 
in turn fuels central fat deposition. A study was conducted using the retrospective cohort 
design, with women selected on the basis of their fat distribution phenotypes. The level 
of life stress and response to stress was studied in all these women. It was found that 
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central fat deposition is related to greater psychological vulnerability to stress and 
cortisol reactivity [50]. A mechanistic study conducted on both male and female adults 
concluded that high levels of cortisol causes fat stores and excess circulating fats to be 
relocated and deposited near the abdomen, resulting in a high waist-hip ratio [51]. It is 
used as an indicator of obesity which in turn is a risk factor for more serious health 
conditions, including heart disease. Hence, waist-hip ratio can capture the general 
health status of an individual.  It is a non-invasive measurement and can be very useful 
in large epidemiological studies. 
 
4.4 GLYCOSYLATED HEMOGLOBIN 
 
Glycosylated hemoglobin is hemoglobin to which glucose is bound. Glucose 
stays attached to hemoglobin for the life of the red blood cell, hence the level of 
glycosylated hemoglobin reflects the average blood glucose level over a period of three 
months [52]. Chronic stress is linked to hyperglycemia [53] This has been explained to 
be caused either due to the presence of excessive counter-regulatory hormones like 
glucagon, glucocorticoids, etc. or due to high circulating or tissue levels of cytokines, 
particularly TNF-α and IL-1, which interfere with the functioning of insulin [54]. 
Hyperglycemia results in elevated levels of glycosylated hemoglobin in chronically 
stressed individuals [55]. Diabetes is a confounding pathological condition, type 2 
diabetes may even be an outcome of chronic stress. It can capture abnormal 
metabolism and risk for cardiovascular disease. It can be useful in epidemiological 
studies, especially those exploring the associations between chronic stress and 
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cardiovascular diseases and can be measured from blood. It can also be used in 
toxicology studies exploring the mechanisms underlying the associations between 
stress and diabetes where the animals being used do not have the disease at the 
beginning, and gradually develop diabetes during the course of the study. 
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5.0 IMMUNOLOGICAL BIOMARKERS 
 
Changes in circulating levels of cytokines are easily quantifiable and hence, can 
be used as biomarkers. IL-6, TNF-α, CRP, and IGF-1 are some of the immune factors 
currently in use as biomarkers for chronic stress.  
 
5.1 IL-6 
 
IL-6 production by peripheral blood mononuclear cultures from chronically 
stressed individuals has been reported to be higher than cultures from control subjects, 
when stimulated by LPS, in a study conducted on older adults [56]. In a longitudinal 
study comparing parents of cancer patients (chronically stressed) and parents of 
healthy children (control), it was reported that chronically stressed persons showed 
higher resistance to anti-inflammatory signals [57]. IL-6 is a pro-inflammatory cytokine 
which works synergistically with TNF-α and IL-1 to cause inflammation, a common 
feature of chronically stressed individuals. It has been used as a biomarker of chronic 
stress in many mechanistic and epidemiological studies because it can be easily 
measured from blood and it can capture pathophysiology of the immune system which 
is an important stress response system [58-59].  
Studies by Sheng and coworkers have suggested that chronically stressed 
individuals are biased toward a humoral immunity oriented cytokine production, for 
unknown reasons [60]. IL-6 is produced in response to stimuli like IL-1 or TNF-α. Stress 
causes the release of IL-1. A properly functioning HPA axis prevents the peripheral 
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release of IL-6 following acute stress [61]. But due to the dysregulation of the HPA axis 
and a resistance to the immunosuppressant effects of glucocorticoids seen in chronic 
stress [62], there may be a decrease in the ability of the HPA to prevent peripheral 
inflammation which accounts for individuals suffering from chronic stress showing 
increased systemic levels of IL-6. Thus, IL-6 is also able to capture indirectly, 
dysfunction of the HPA axis.  
 
5.2 TNF-α 
 
TNF-α is a pro-inflammatory cytokine, produced mainly by activated 
macrophages. Together with IL-1 and IL-6, it is involved in the suppression of appetite, 
increasing insulin resistance, promotion of expression of adhesion molecules on 
endothelial cells to aid neutrophil migration, etc. It may also be involved in central 
nervous system pathology because it has been associated with demyelination [63]. 
TNF-α levels have been reported to be increased in adults aged 19-55, under chronic 
stress [64]. TNF-α promotes gene expression by activating NFκB which results in the 
transcription of inflammatory cytokines [65]. Hence, an elevation in TNF-α is 
concomitant with elevation in the levels of IL-1 and IL-6. The mRNA of TNF-α is higher 
during chronic stress, which suggests denovo synthesis rather than the release of 
preformed inducible protein upon activation of lymphocytes and macrophages [66]. The 
levels of spontaneously produced TNF-α are also reported to be higher in persons 
suffering from chronic stress, as compared to controls [67]. This increase in TNF-α 
production can be explained similarly to the increase in IL-6 levels. A dysregulated HPA 
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axis, unable to prevent peripheral inflammation, combined with a loss of sensitivity to 
glucocorticoid inhibition results in high levels of TNF-α. It captures the inflammatory 
outcomes of HPA axis dysregulation mediated by glucocorticoid signaling. It can be 
useful in epidemiological studies because sample (blood) collection is relatively easy. 
However, a study conducted on young adults have shown that the production of TNF-α 
is inhibited by glucocorticoids under chronic stress [68].  
 
5.3 CRP 
 
C-reactive protein (CRP) is a protein found in the blood, the levels of which rise 
in response to inflammation. Its physiological role is to bind to the phosphocholine 
expressed on the surface of apoptotic cells in order to activate the compliment system 
[69]. Measuring CRP is a marker for inflammatory diseases. Since chronic stress is 
known to induce the production of IL-1 and a subsequent chronic low-grade 
inflammation, CRP levels can be used as a screen for this inflammatory response due 
to chronic stress. In a study conducted on adolescents, under chronic stress, CRP 
levels have been suggested to rise [70]. CRP can be measured from blood and has 
been successfully used in epidemiology studies as a marker of the chronic inflammatory 
response caused by chronic stress [71]. Some sex differences have been reported with 
women showing higher CRP levels than men, however, the level of CRP has been 
reported to rise in both the sexes with exposure to chronic stress [72].  
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5.4 IGF-1 
 
IGF-1 or Insulin-like growth factor-1, is a hormone with a structure similar to 
insulin, synthesized by the liver and other cell types. It has anabolic effects in adults and 
is important for growth during childhood. Growth hormone induces the production of 
IGF-1. It is a potent inhibitor of programmed cell death and a stimulator of cell growth 
and proliferation. The normal range of IGF-1 in blood is 10-1000 ng/ml. A decrease in 
growth hormone levels results in a decrease in IGF-1 levels [73]. ACTH and 
noradrenaline influence cellular immunity by decreasing mitogen responsiveness of 
lymphocytes. This results in impaired production of IGF-1 by lymphocytes [73]. 
Glucocorticoids have catabolic effects [74]. They reduce the responsiveness of various 
cell types to anabolic hormones. High levels of circulating glucocorticoids result in 
inadequate anabolic hormone synthesis. This causes a catabolic/anabolic imbalance 
[75]. Hence, in adults under chronic stress, higher than normal levels of cortisol have 
been suggested to result in low levels of IGF-1 [76-77].  
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6.0 THE NEUROENDOCRINE SYSTEM 
 
The neuro-endocrine system consists of neurons and endocrine glands and the 
interactions between them [78]. The main component of the neuro-endocrine system is 
the hypothalamus-pituitary-adrenal axis or HPA axis. Apart from controlling reactions to 
stress, the HPA axis regulates digestion, immune function, mood and emotions [79].  
 
6.1 THE HPA AXIS 
 
The hypothalamus contains neuroendocrine neurons that synthesize and secrete 
vasopressin and corticotrophin releasing hormone (CRH) which regulate the pituitary 
gland and stimulate the production of adrenocorticotropic hormone (ACTH) which in turn 
stimulates the adrenal cortices to produce glucocorticoids, mainly cortisol. The 
glucocorticoids act on the hypothalamus and pituitary, to suppress the production of 
CRH and ACTH, thus completing the negative feedback circuit [80]. Adrenaline and 
Noradrenaline are secreted by the adrenal medulla via sympathetic nervous stimulation 
and local effects of cortisol. These enzymes positively feedback to the pituitary and 
increase the production of ACTH. Various neurotransmitters, like dopamine and 
serotonin are involved in regulating the HPA axis [80]. 
Real or interpreted threats to homeostasis induce the release of adrenaline and 
noradrenaline, along with glucocorticoids, and the fight-or-flight response is initiated 
under acute stress. Under chronic stress, the HPA axis is stimulated for prolonged 
periods of time. The hyperactivity of the HPA axis causes the related biological systems 
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to overcompensate and eventually collapse [81]. HPA axis dysfunction, caused by 
chronic stress may present itself as hypercortisolism, hypocortisolism or some form of 
diurnal dysrhythmia [82]. ACTH which is elevated under chronic stress, induces an 
elevation in the levels of cortisol and depletion of other glucocorticoids through the 
already described pregnenolone steal. This phase of hypercortisolism can last for 
several years, but eventually leads to the attenuation of stress response due to 
habituation of the HPA axis, resulting in reduced cortisol production and eventually 
hypocortisolism [83].  
The HPA axis thus shifts from a hyper-responsive state to a hypo-responsive 
state, and eventually digress to an unresponsive state. This stage is called “adrenal 
fatigue”. This attenuation of the stress response might be a defensive mechanism to 
prevent long term suppression of immune function. But it has many negative 
consequences, like impaired cognition, sleep disturbances, anorexia, etc [84].  
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7.0 NEUROENDOCRINE BIOMARKERS 
  
Neuroendocrine factors are effective as biomarkers for stress because, the 
neuroendocrine system is the first to respond to a given stressor, and coordinates the 
response of many other physiologic systems to the stressor, including cardiovascular 
and immune systems, as well as energy production and/or utilization and behavior, 
therefore bringing the body back to homeostasis [2]. Neuroendocrine factors are also 
very easy to measure. Even a mild challenge can trigger a response from this system 
and small changes from normal levels of neuroendocrine factors can be effectively 
detected [85-86]. 
The various neuroendocrine biomarkers of chronic stress currently in use include 
Cortisol, Dehydroepiandrosterone, Aldrenaline, Noradrenaline, Dopamine, and 
Aldosterone. 
 
7.1 CORTISOL 
 
Cortisol is a glucocorticoid synthesized by the adrenal cortex [86]. It has 
important immunosuppressive and anti-inflammatory effects [87]. It is also involved in 
the conversion of stored fats and proteins into carbohydrates [88]. It causes an increase 
in heart rate and blood pressure [89]; and suppression of growth, digestive and 
reproductive activities [90]. It is capable of traversing the blood brain barrier and 
modulating the functions of the prefrontal cortex and limbic lobe [91].  
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The amount of cortisol in the blood undergoes diurnal variation. The level peaks 
in the early morning and reaches its lowest level three to five hours after the onset of 
sleep [92]. Studies conducted on healthy adults suggested that Chronic stressors that 
threaten physical integrity, are uncontrollable, or involve trauma tend to result in a high 
flat diurnal profile of cortisol release, with lower than normal levels in the morning and 
higher than normal levels in the evening and controllable chronic stressors tend to 
produce higher than normal morning levels of cortisol [93]. A study conducted on male 
rats inferred that the period following cessation of chronic stress is associated with HPA 
axis hypoactivity [94]. This produces a glucocorticoid deficient state and lead to relative 
resistance to infection, but greater susceptibility to autoimmune inflammatory diseases. 
This hypoactivation of the HPA axis is also seen in disease states like chronic fatigue 
syndrome, where the dysregulation is due to habituation of the HPA axis to the constant 
stimulation by the chronic stressor, which results in the shutdown of the stress response 
[95].  
Cortisol can be measured from urine [96], saliva [97] or serum [98]. Cortisol 
measurements directly capture the status of HPA axis functioning which is a mediator of 
many secondary outcomes, ultimately leading to disease. Studies have suggested that 
during acute stress, there is a spike in cortisol levels following exposure to the acute 
stressor and the levels return to normal once the stress has been resolved [99-101].  
Due to the large diurnal variation in cortisol levels which make it difficult to 
ascertain the levels from a single measurement, it is not generally effective as a 
biomarker for chronic stress – except in studies where temporally dense repeated 
measures of cortisol can be obtained from the same subjects, to examine diurnal trends 
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and cortisol responsivity within the subjects.. Also, habituation to chronic stress causes 
a down-regulation of the glucocorticoid response which leads to dissociation between 
chronic stress and cortisol levels [102]. Apart from stress, other factors like injury [103], 
genetic factors, sex, smoking habits, social support, individual sleep cycle [104], obesity 
[105], etc influence cortisol levels. 
 
7.2 DEHYDROEPIANDROSTERONE 
 
Dehydroepiandrosterone (DHEA) is an androgen synthesized by the adrenal 
glands [106]. It functions as a HPA axis antagonist [107-108]. It also suppresses 
inflammatory cytokines [109], improves lipid metabolism and lean muscle mass [110], 
decreases insulin resistance and reduces oxidative brain damage [111-112]. 
DHEA is produced from cholesterol through the cytochrome P450 enzymes 
P450scc and CYP17A1 [113]. Dehydroepiandrosterone sulphate is the sulphated 
version of dehydroepiandrosterone. The conversion is reversibly catalysed by 
sulfotransferase SULT2A1, primarily in the adrenals, liver and small intestine. In blood 
most dehydroepiandrosterone is found in the sulphated form [114]. The levels of both 
forms peak in the early morning hours [115]. In healthy adults, in response to a chronic 
stressor, the dehydroepiandrosterone levels have been reported to fall during the hyper-
responsive stage of the HPA axis. Even though cortisol production is attenuated once 
the shift to the hypo-responsive stage of the HPA axis occurs, DHEA levels have been 
shown to continue to drop [116]. It can be measured from serum [117], saliva [118] and 
urine [119]. DHEA measurements directly capture the status of HPA axis functioning. 
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In response to acute stress, DHEA levels have been reported to rise [120]. Apart 
from chronic stress, drugs like insulin [121], opiates, corticosteroids, etc and other 
factors like age [122], certain illnesses like skin diseases [123], etc lower DHEA levels. 
Hence, low levels of DHEA do not always correlate with chronic stress. The absolute 
levels of cortisol or DHEA may not always point to a dysregulation of the HPA axis, but 
the ratio of Cortisol:DHEA can be used to determine how an individual`s HPA axis is 
functioning. Under chronic stress, the ratio is reported to be significantly higher than in 
normal individuals. This is mainly due to decreased DHEA production [124]. High 
Cortisol:DHEA ratio has been successfully used to diagnose treatment resistant 
depression [125] and to predict success of smoking cessation efforts [126]. Diurnal 
variation exists in the levels of DHEA and DHEA-S. The peak levels occur in the 
morning. Hence, when measuring DHEA as a marker of chronic stress, it is important to 
obtain temporally dense, repeated measures from every subject. Since this is a time 
consuming process, it is not feasible to use DHEA as a marker for chronic stress in 
large cohort studies. It may be more useful in mechanistic studies or small case-control 
studies. 
 
7.3 ADRENALINE 
 
Adrenaline is a catecholamine synthesized by the adrenal glands. It increases 
heart rate [127], glucose levels [128], decreases digestion, and reduces the activity of 
the parasympathetic nervous system as part of the fight-or-flight response [103]. 
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Adrenaline is released as a result of sympathetic nervous stimulation of the 
adrenal medulla, usually in response to stress [129]. Chronically stressed individuals 
have been reported to show low adrenaline responsivity due to habituation to constant 
adrenaline induced signaling [130]. Chronic stress in adult male rats has been shown to 
elevate the absolute concentration of adrenaline by decreasing its turnover rate [131-
132]. Also, there is a sustained increased production of adrenaline by the adrenal 
glands due to sympathetic nervous stimulation. It can be measured from plasma [133] 
and urine [134]. By measuring adrenaline levels, the state of sympathetic nervous 
system function can be captured. Recently, chronically elevated levels of adrenaline 
have been linked to DNA damage caused by lowering of p53 levels [135].  
Acute stress in healthy adults has been reported to cause an elevation of 
adrenaline levels, but this is due to increase in production [136]. Due to this reason, it is 
difficult to attribute the rise in adrenaline levels to acute or chronic stressors. Even 
though adrenaline is the hormone which most consistently responds to stress, it also 
responds to any experience that causes mental arousal or requires effort, regardless of 
whether it is perceived as a threat or as an opportunity for gain. Hence, it is not as 
useful as a biomarker of stress.  
 
7.4 NORADRENALINE 
 
Noradrenaline is a catecholamine synthesized by the adrenal medulla, the 
peripheral sympathetic nerves and the central nervous system [137]. It increases blood 
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pressure and heart rate [138-139], causes vasoconstriction [139], and modulates brain 
functions as part of the fight-or-flight response [140]. 
Noradrenaline is a neurotransmitter that has widespread effects across multiple 
brain areas. Studies in rats have suggested that Plasma levels of noradrenaline are 
elevated [141] and studies in adult humans have suggested that there is a decrease in 
the release of brain noradrenaline under chronic stress [142]. A study conducted in 
adult humans and monkeys have reported that there is also an upregulation of post-
synaptic receptor, atrophy of noradrenaline axon projections and reduced transmission 
[143]. It can be useful in epidemiological studies since it can be easily measured from 
plasma [133], cerebrospinal fluid [144] or urine [134]. By measuring adrenaline levels, 
the state of sympathetic nervous system function can be captured. 
Acute stress has been reported to cause an elevation in both plasma [145] and 
brain [146] noradrenaline levels. Essential hypertension [147], diet [148], recreational 
drug use [149], exercise [150], sex [151], etc influence noradrenaline levels, making it 
an unreliable biomarker when used on its own. When used in conjunction with other 
markers of chronic stress in an allostatic load model, it can be one of the useful pointers 
of sympathetic nervous system functioning.  
 
7.5 DOPAMINE 
 
Dopamine is a precursor of noradrenaline, synthesized in the brain [137].  It 
increases the overall renal perfusion [152] and has a diuretic effect [153]. It increases 
heart rate and blood pressure [128] and also functions as a neurotransmitter which is 
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involved in many activities like voluntary movement [154], motivation [155-156] and 
cognition [157-158]. 
Chronic stress is linked to impaired working memory due to reduced transmission 
of dopamine, combined with an increase in dopamine D1 receptor density in the 
prefrontal cortex region of the brain of rats [159]. In rats, extraneuronal dopamine is 
reported to be reduced during chronic stress [160] due to reduced activity of 
dopaminergic neurons and not due to reduced synthesis of dopamine or enhanced 
reuptake [161]. Dopamine can be measured from urine [162], plasma [163] and 
cerebrospinal fluid [144]. The D1 receptor binding can be measured using PET [164]. 
Acute stress is reported to cause an increase in dopamine release in rats [160, 
165]. Recreational drug use and later abstinence [166-167], exposure to chemicals like 
PCBs [168], exercise [169], obesity [170], feeding habits [171], etc influence dopamine 
levels. Hence, the use of dopamine alone as a biomarker of chronic stress is not 
reliable. When used in conjunction with other markers as part of the allostatic load 
model, it can be one of the useful biomarkers for quantifying stress response. It is a 
mediator of behavioral and to a lesser extent, cardiovascular outcomes of stress. 
 
7.6 ALDOSTERONE 
 
Aldosterone is a mineralocorticoid synthesized by the adrenal glands [172]. It 
acts on the CNS via the posterior pituitary gland and causes the release of anti-diuretic 
hormone. It also influences the cardiovascular system by causing localized vasodilation 
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at the site of action [173]. It is involved in reabsorbing sodium, water retention and 
potassium excretion in order to maintain blood acidity [174]. 
Studies in rats have suggested that aldosterone secretion is reduced due to 
chronic stress [175]. This can result in hyperkalemia and hyponatremia [176]. 
Aldosterone can be measured from urine [177], plasma [178] and serum [179]. 
Acute stress is reported to cause an elevation in aldosterone secretion [180]. The 
standalone use of aldosterone as a biomarker for chronic stress is unreliable because 
smoking [181], diet [182], etc. influence aldosterone levels. The effect of these 
confounding factors can be minimized when it is used in conjunction with other markers 
as part of the allostatic load model. As part of a consortium of markers measuring 
allostatic load, aldosterone can be a useful measure of functioning of the adrenal gland. 
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8.0 ALLOSTATIC LOAD MODEL 
 
The use of any single biomarker for measuring stress is associated with 
problems. The current approach is to use multiple markers to measure the effects of 
stress on various bodily systems. Allostasis is defined as the process by which an 
organism maintains physiological stability by changing parameters of its internal milieu 
by matching them appropriately to environmental demands [183]. According to 
McEwen, “Allostatic load refers to the price the body pays for being forced to adapt to 
adverse psychological or physical situations, and it represents either the presence of 
too much stress, or the inefficient operation of the stress hormone response system” 
[184].  Normally, once allostasis is initiated by a stressor, it is sustained for an 
appropriate period of time and then turned off. Frequent initiation of allostasis by 
multiple stressors may lead to either the body not turning off the response or not 
responding sufficiently. Lack of adaptation to a recurring stressor, failure to turn off 
adaptive responses upon   initiation by a stressor, failure to sufficiently respond to a 
given stressor are other types of abnormal allostatic responses. These can be better 
explained by the following graph by McEwen [185]. 
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Figure 2. TYPES OF ALLOSTATIC LOAD 
Allostatic load is calculated by including information about the status of all major 
physiological regulatory systems. The allostatic load model expands the theory of 
allostasis by applying it to study the effects of chronic stress. In the initial studies done 
to validate the allostatic load model, McArthur Successful Aging Study data was used 
and this data contained information about the physiological status of the HPA axis, 
sympathetic nervous system, metabolic processes and cardiovascular system of the 
study subjects [186]. In total, 10 parameters were included in the study and of these, 4 
parameters, namely DHEA, cortisol, adrenaline and noradrenaline were primary 
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mediators of the stress response, and the remaining 6 parameters were indices of 
outcomes. Many studies have utilized the allostatic load model to quantify stress. In 
these studies, biomarkers encompassing neuroendocrine, cardiovascular, immune and 
metabolic parameters are measured as a suite. Ideally, both resting and changes in 
resting levels of these biomarkers are measured, and an allostatic load score is given to 
each study subject by summing the number of indices for which the subject fell into the 
highest risk group. A high allostatic load score would mean that the subject is 
experiencing high levels of chronic stress and is at a greater risk of morbidity due to 
chronic stress. Many studies have utilized the allostatic load model to make predictions 
about the health outcomes following exposure to chronic stress [19, 59, 187-188]. 
   An individual`s behavior can either increase or decrease the risk for disease. 
For example, if an individual takes up smoking as a result of psychosocial stress, the 
risk of several chronic disorders is increased, but if an individual`s behavior helps in 
increasing stress buffering systems, say social connections, the risk of developing an 
undesired health outcome due to stress exposure can be decreased. Genetics and 
family history of a given disease also modifies an individual`s risk for developing the 
disease. Sociological factors also modify risk of disease. For example, an individual with 
low socioeconomic status may not have the same kind of access to healthcare services 
as an individual with higher socioeconomic status and this may increase the risk of 
developing a more serious form of the disease due to lack of early diagnosis and 
treatment in the individual with lower socioeconomic status. Since behavioral, 
sociological and genetic factors modify the risk of disease in an individual, the allostatic 
load model can be made more robust by incorporating indices of these risk factors for 
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the health outcome being measured. The strength of the allostatic load model is that it 
captures variation across multiple physiological domains impacted by stress, and by 
virtue of being multi-dimensional, can better isolate effects of stress from other 
exposures because, it is unlikely that any given pathological condition would affect all 
the indices being measured in the same manner as chronic stress. Using factor 
analysis, suppose it is hypothesized that the same set of biomarkers (variables) are the 
primary mediators and indicators of secondary outcomes of chronic stress and a given 
pathological state (the factors), an exploratory factor analysis can be carried out to 
unearth the underlying structure of relationships of the variables to the factors. A high 
allostatic load score usually translates into higher risk of morbidity.  Any new information 
emerging about either the stress response or the health outcomes of interest is also 
very easy to incorporate into the model.  
The set of indicators to be used in a given study are arbitrarily chosen by the 
researcher. It would be ideal to use those biomarkers which are indicative of health 
status not revealed by self reports of stress. Also, the weighted scores given to each 
indicator that is measured is arbitrary. There is no standardization with regards to which 
indicators must be given a higher weighted score and which indicators must be given a 
lower weighted score. Depending on what data is available, researchers have adapted 
the methodology used to arrive at the allostatic load score. An important question to be 
answered is, what do the levels of biomarkers mean at different points in the life of an 
individual and is the functional significance of a given level of biomarker different for 
different ethnicities and sex? Another important question to be answered is if various 
kinds of psychosocial stress causes the same kind of allostatic load profile. Most of the 
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biomarkers measured to arrive at the allostatic load score are biologically 
interconnected. Change in one parameter will consequently result in changes in all 
other physiologically interconnected parameters due to positive and negative feedback 
mechanisms, hence making it difficult to ascertain which parameter is a primary 
mediator and which parameter is a secondary outcome. Though allostatic load reflects 
cumulative exposures to stress over many years, most allostatic load studies are of a 
cross sectional nature when it comes to throwing light on changes to the allostatic 
profile over time. Longitudinal measurement of allostatic load can give information about 
the allostatic profile of an individual at various stages of developing stress related health 
outcomes. This can give some insight into the pathways of pathophysiology leading to 
the development of disease.  
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9.0 PROMISING NEW VISTAS FOR CHRONIC STRESS CHARACTERIZATION 
 
 9.1 METABOLOMICS  
 
Metabolomics is defined as “the systematic study of the unique chemical 
fingerprints that specific cellular processes leave behind” [189]. For many years 
physicians and scientists have known that metabolites play an important role in 
pathology and that by identifying the metabolites, clues to the underlying disease can be 
obtained. But the “omics” approach to studying metabolites is relatively new. It is said 
that “small changes in fluxes through pathways can lead to large changes in the 
concentration of metabolites” [190], hence metabolomics can identify any small 
discrepancies in normal functioning of enzymes and thus point to a possible pathology 
where other techniques might not be able to do so. Since stress influences digestion 
and digestive enzymes [204], it is natural that a comparison of stressed vs. unstressed 
metabolomes would yield interesting results. A recent study has used the metabolomics 
approach to identify biomarkers of chronic stress in rats. Blood collected under 
anesthesia was analysed using NMR. Differences were observed in the spectra 
between control and stressed rats. The stressed phenotype showed increases in 
plasma lactic acid, choline, NAC and decreases in HDL, unsaturated fatty acids and 
unknown components [191]. If the spectra for acute stress can be obtained and 
compared to the spectra of chronically stressed rats, and if these two spectra are 
considerably different from each other; and if the spectrum of chronic stress is 
considerably different from the spectra obtained from known pathological states 
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commonly affecting stress response systems, such a spectrum may be used as a 
biomarker in rats and a similar approach can be pursued to identify the differences in 
spectra of human control and chronically stressed individuals. Using human samples, 
metabolome of acute stress has already been studied and is available for comparison 
with chronic stress cases. The metabolites that are significantly different from control 
groups have been identified as lactate, pyruvate, alanine, and hypoxanthine [192].  
Another study used liver metabolic gene profiling in mice to characterize shifts in 
energy metabolism that result from acute and chronic stress. In this study, 
hypercatabolic activity is presented as a hallmark of chronic stress [193]. If the pattern 
of gene regulation is significantly different from those for known pathological conditions 
affecting the stress response systems, the gene profile can be used as an indicator of 
chronic stress in mice and the study can be repeated for human metabolic genes. 
The metabolomics approach to characterization of stress can be used mainly to 
make judgments about the stress response component of the stress chain. It remains to 
be seen if various types of chronic stressors give rise to similar metabolite signatures. If 
so, more research needs to be done in order to associate a particular level of stressor 
exposure to a particular metabolic signature. If the various kinds of chronic stressors do 
not have a common metabolic signature, further research to link a particular level of a 
given stressor to a particular metabolic signature needs to be carried out. If this is done, 
metabolomics of chronic stress can be used to make quantitative judgments about the 
level of chronic stress experienced by a person, after taking into account, the appraisal 
of the stressor. In toxicology, it is said that the dose makes the poison. Quantifying the 
level of chronic stress is important to determine the “dose” of chronic stress which is 
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detrimental to health and if there is a proverbial NOEL (No observed effect level). 
Objective quantification of chronic stress can make this technique very useful for 
mechanistic studies. Even though sample (blood) collection is fairly easy, the high cost 
and skill level involved in performing this technique would make it difficult to use in large 
epidemiology studies. 
Mass spectrometry methods currently being employed in metabolomics studies 
can provide accurate and reproducible qualitative and quantitative assessments of a 
large complement of the metabolome, but the time required to analyze large sample 
numbers can be very lengthy. Hence, parallel processing of samples to allow high 
throughput screening would complement the comprehensive metabolome-wide 
screening. But, the disadvantage of such a high throughput assay would be the 
predetermination of metabolites to be screened, which can present a bias in the 
metabolite patterns observed. A method combining the advantages of the high 
throughput screening and the comprehensive metabolome screening can be used. 
Multiple correlations of metabolites are commonly observed in metabolomics studies [6]. 
If a set of representatives could be identified such that the metabolites can capture 
much of the variance within a metabolome which is potentially diagnostic of changes 
due to stress, if the metabolites are relatively independent of each other and are not 
commonly found in some known pathological conditions, then the resultant set of 
biomarker metabolites could be used for screening of metabolite patterns as a result of 
chronic stress, and a metabolite signature diagnostic for chronic stress could then 
emerge. The ability of the biomarker set to faithfully represent the pattern of variation 
among the various tissues (potentially in humans, blood draw and urine sample) 
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sampled in the body can provide a type of internal validation. The biomarker metabolite 
set should be able to discern the same pattern of relationships based on correlations as 
those correlations derived from a comprehensive metabolite dataset. The biomarker 
metabolites can be arrived at by subjecting the metabolome profiles of chronic stress 
and some known pathologies to principal component analysis and subsequent K-means 
clustering. Representatives from the clusters can be chosen based on their proximity to 
the center of the cluster and their relative rarity in all the metabolic profiles studied 
except chronic stress. 
The advantage of using metabolomics is that it measures the phenotype of an 
organism. When an organism becomes diseased or stressed, it triggers specific 
molecular changes and the phenotype becomes altered. This change can then be 
measured using metabolomics. Doctors have used metabolites to diagnose various 
health conditions, for example, glucose measurement has been used to diagnose 
diabetes, so the concept is not new, but using metabolomics, a comprehensive set of 
metabolites can be measured and this gives a clearer picture of the health status of the 
individual. 
 
 9.2 ULTRASTRUCTURE MODIFICATIONS IN MITOCHONDRIA  
 
Mitochondrion is a membrane bound organelle found in most eukaryotic cells. 
Mitochondria are considered the power house of the cell because it is the site of ATP 
synthesis. The mitochondrion consists of a phospholipid bilayer, an inter-membrane 
space and the matrix (the space enclosed by the inner membrane, which contains the 
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mitochondrial DNA and proteins). The inner membrane of the mitochondrion invaginates 
into the matrix and the invaginations are called cristae. The diameter of mitochondria 
ranges from 0.5 to 10 microns [194]. Ultrastucture of mitochondria of masticatory 
muscles was recently shown to be altered under chronic stress in rats. Swollen 
mitochondria with cristae loss and reduced matrix density was observed after 3 weeks 
of stimulation and after 5 weeks, severe vacuolar changes were observed by TEM. 
Anaerobic metabolism was also increased [195]. Oxidative stress is also known to 
cause reduced matrix density and disorganization of cristae, but in a reversible manner 
[196]. In humans, chronic stress is known to cause masticatory muscle disorder [197], 
hence these findings may be significant. In order to use the morphological changes of 
mitochondria as biomarkers for chronic stress, it would be important to find out if the 
changes caused by chronic stress are reversible. If the kinetics of reversion are different 
from the kinetics of reversion of oxidative stress, the change in ultrastructure can be 
used as an indicator of the stress response component of the chronic stress chain. A 
buccal swab can give enough cells to observe mitochondrial changes. But buccal 
epithelium is subject to other stressors like mechanical stress which can also cause the 
said changes, but these can be accounted for by using appropriate non-stressed 
controls who also experience the other non-psychosocial stresses affecting the buccal 
epithelium, in the experimental or epidemiological studies. Also, mitochondrial fission 
shows characteristics similar to those observed for chronic stress. Mitochondria are 
constantly undergoing fission and fusion. Hence, it is necessary to differentiate these 
normal changes from those induced by chronic stress. It is most likely that the 
fragmentation of mitochondria that is observed under chronic stress is due to 
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unbalanced fission [198]. Markers of fission (Fis1) and fusion (DLP1, Mfn1, Mfn2, etc) 
[199] can be measured and if fission proteins are elevated and fusion proteins are 
decreased, the changes can be attributed to pathophysiology of chronic stress. Buccal 
swab collection is noninvasive and inexpensive, making ultrasturcture changes in 
mitochondria easy to use for large epidemiological studies. The intensity of 
ultrastructure integrity loss can be related to the length of time under stress; hence it 
can be incorporated easily into the allostatic load model to not only provide information 
about the secondary outcomes of stress, but potentially also about the duration and 
intensity of stressor exposure. 
 
    9.3 DRR1 INDUCTION IN BRAIN 
 
DRR1 is a tumour suppressor gene which was recently described as inducible by 
chronic stress in the brain. Theo Rein et. al. reported in a recently published study 
conducted on rats that DRR1 has the ability to bind to and remodel actin filaments, 
which are important components of pre-synaptic and post-synaptic structures [200]. 
Hence, DRR1 can potentially impact neuroplasticity and information processing by 
altering the interplay between pre- and post-synaptic structures. It was reported by the 
same group that DRR1 is prominently expressed and induced by chronic stress in the 
hippocampus [201]. It is widely regarded that chronic stress mediates changes in 
neuroplasticity [202-203]. It is possible that DRR1 plays a role in this mediation. A 
possible link between elevation of DRR1 expression in the brain and behavioral 
changes in the rats has to be explored. If DRR1 can be mechanistically linked to 
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behavioral changes, it can be used as a biomarker of chronic stress response in rats to 
be used in other mechanistic studies exploring the link between chronic stress exposure 
and health outcomes. This cannot be applied to humans as it is induced only in the 
hippocampus region of the brain and therefore, obtaining a tissue sample for measuring 
DRR1 levels in live subjects is not possible. If there are paralogs of the protein, being 
expressed in other cell types which can be sampled from humans, it might be useful to 
see if those proteins are also stress inducible in a manner consistent with DRR1. A 
BLAST search of DRR1 (Accession number NP_001070246.1) with search criteria set 
as all non-redundant GenBank CDS translations+PDB+SwissProt+PIR+PRF excluding 
environmental samples from WGS projects, search algorithm set as blastp [205], 
yielded several hypothetical proteins, proteins of unknown functions and proteins 
normally expressed by cells of the nervous system. This makes it difficult to come up 
with any proxy measures that could be captured in humans. 
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10.0 CONCLUSIONS 
 
 Stress, unlike any other pathological condition, triggers a non-specific response 
and influences multiple physiological systems [2]. In order to conduct research on a 
given condition, it is very important to characterize that condition and be able to 
objectively measure its indices. Chronic stress was traditionally measured using 
questionnaires which measured stressor exposure and affect, like the perceived stress 
scale, POMS questionnaire and major life events scale. Even though high scores on 
these questionnaires correlated with greater susceptibility to stress related illness, the 
measurements obtained using these instruments were arbitrary and subjective. The use 
of biomarkers can solve the problems of arbitrariness and subjectivity. But biomarkers 
suffer from problems with multiple determinations. Also, biomarkers cannot capture 
information regarding stress appraisal, which plays a major role in determining of a 
given stressor is stressful or not. Hence, ideally a study would use a set of biomarkers 
(allostatic load model) to objectively measure the stress response, while using the 
questionnaires to measure stressor exposure and stress appraisal. Using statistical 
methods, the allostatic load score and the scores on the questionnaires can be 
combined to give one composite score which would be more effective in predicting 
susceptibility to stress related diseases. The challenge lies in fine tuning the allostatic 
load model so as to capture only chronic psychosocial stress related information and 
weed out other confounding factors like exposure to biochemical and physical stressors 
as much as possible. Some of the recent research has thrown up some interesting 
possibilities, which if followed up on, could lead to novel methods of chronic stress 
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measurement which could be added to the allostatic load model to make it more robust. 
With the help of objective measurements, studies exploring the physiological and 
pathophysiological effects of chronic stress can be conducted and the mystery of being 
generally ill, as Selye put it, can be solved. 
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